Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy
Hepatocellular carcinoma (HCC) is ranked as the second leading cancer-related death in the world. Chemotherapy is one of the most commonly used strategies for HCC patients, while the clinical application is hampered by its cytotoxicity. To address this dilemma, tumor-targeted nanotechnology has been...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Advances in Materials Science and Engineering |
Online Access: | http://dx.doi.org/10.1155/2022/3986373 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832561651632570368 |
---|---|
author | Min Guo Ying Tang Liang Hua Wanling Li Guifang Gong Yali Zhu Bing Zhu Yu Xia |
author_facet | Min Guo Ying Tang Liang Hua Wanling Li Guifang Gong Yali Zhu Bing Zhu Yu Xia |
author_sort | Min Guo |
collection | DOAJ |
description | Hepatocellular carcinoma (HCC) is ranked as the second leading cancer-related death in the world. Chemotherapy is one of the most commonly used strategies for HCC patients, while the clinical application is hampered by its cytotoxicity. To address this dilemma, tumor-targeted nanotechnology has been proposed to balance the toxicity and efficacy of chemotherapy. Tumor-targeted selenium nanoparticles (HA-SeNPs) were prepared to load an anticancer drug doxorubicin (DOX). In this drug delivery system, hyaluronic acid (HA) was used as a tumor-targeted moiety to bind with its receptor highly expressed in hepatocellular carcinoma cells. The transmission electron microscopy (TEM) and dynamic light scattering assays showed that HA-Se@DOX was a small and high stable nanocomposite. The cell viability, scratch migration, and invasion chamber assays indicated that HA-Se@DOX showed stronger ability to suppress HepG2 cells growth and migration/invasion compared to Se@DOX or DOX alone. Moreover, HA-Se@DOX could induce HepG2 cells apoptosis probably through the reactive oxygen species (ROS). In summary, the results indicated that HA-Se@DOX exhibits great potential to be a prodrug against hepatocellular carcinoma. |
format | Article |
id | doaj-art-8eb89a7028794b5e8fce339cb0393150 |
institution | Kabale University |
issn | 1687-8442 |
language | English |
publishDate | 2022-01-01 |
publisher | Wiley |
record_format | Article |
series | Advances in Materials Science and Engineering |
spelling | doaj-art-8eb89a7028794b5e8fce339cb03931502025-02-03T01:24:29ZengWileyAdvances in Materials Science and Engineering1687-84422022-01-01202210.1155/2022/3986373Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma TherapyMin Guo0Ying Tang1Liang Hua2Wanling Li3Guifang Gong4Yali Zhu5Bing Zhu6Yu Xia7Center LaboratoryCenter LaboratoryCenter LaboratoryCenter LaboratoryDepartment of Obstetrics and GynecologyDepartment of Obstetrics and GynecologyCenter LaboratoryDepartment of Gastroenterology and HepatologyHepatocellular carcinoma (HCC) is ranked as the second leading cancer-related death in the world. Chemotherapy is one of the most commonly used strategies for HCC patients, while the clinical application is hampered by its cytotoxicity. To address this dilemma, tumor-targeted nanotechnology has been proposed to balance the toxicity and efficacy of chemotherapy. Tumor-targeted selenium nanoparticles (HA-SeNPs) were prepared to load an anticancer drug doxorubicin (DOX). In this drug delivery system, hyaluronic acid (HA) was used as a tumor-targeted moiety to bind with its receptor highly expressed in hepatocellular carcinoma cells. The transmission electron microscopy (TEM) and dynamic light scattering assays showed that HA-Se@DOX was a small and high stable nanocomposite. The cell viability, scratch migration, and invasion chamber assays indicated that HA-Se@DOX showed stronger ability to suppress HepG2 cells growth and migration/invasion compared to Se@DOX or DOX alone. Moreover, HA-Se@DOX could induce HepG2 cells apoptosis probably through the reactive oxygen species (ROS). In summary, the results indicated that HA-Se@DOX exhibits great potential to be a prodrug against hepatocellular carcinoma.http://dx.doi.org/10.1155/2022/3986373 |
spellingShingle | Min Guo Ying Tang Liang Hua Wanling Li Guifang Gong Yali Zhu Bing Zhu Yu Xia Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy Advances in Materials Science and Engineering |
title | Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy |
title_full | Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy |
title_fullStr | Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy |
title_full_unstemmed | Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy |
title_short | Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy |
title_sort | functionalized selenium nanoparticles enhance anticancer efficacy of doxorubicin for hepatocellular carcinoma therapy |
url | http://dx.doi.org/10.1155/2022/3986373 |
work_keys_str_mv | AT minguo functionalizedseleniumnanoparticlesenhanceanticancerefficacyofdoxorubicinforhepatocellularcarcinomatherapy AT yingtang functionalizedseleniumnanoparticlesenhanceanticancerefficacyofdoxorubicinforhepatocellularcarcinomatherapy AT lianghua functionalizedseleniumnanoparticlesenhanceanticancerefficacyofdoxorubicinforhepatocellularcarcinomatherapy AT wanlingli functionalizedseleniumnanoparticlesenhanceanticancerefficacyofdoxorubicinforhepatocellularcarcinomatherapy AT guifanggong functionalizedseleniumnanoparticlesenhanceanticancerefficacyofdoxorubicinforhepatocellularcarcinomatherapy AT yalizhu functionalizedseleniumnanoparticlesenhanceanticancerefficacyofdoxorubicinforhepatocellularcarcinomatherapy AT bingzhu functionalizedseleniumnanoparticlesenhanceanticancerefficacyofdoxorubicinforhepatocellularcarcinomatherapy AT yuxia functionalizedseleniumnanoparticlesenhanceanticancerefficacyofdoxorubicinforhepatocellularcarcinomatherapy |